{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T16:03:16Z","timestamp":1791043396265,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.clon.2017.01.009","type":"journal-article","created":{"date-parts":[[2017,2,15]],"date-time":"2017-02-15T00:30:16Z","timestamp":1487118616000},"page":"378-384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic Review"],"prefix":"10.1016","volume":"29","author":[{"given":"L.C.","family":"Mendez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Barbera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2017.01.009_bib1","unstructured":"cancerresearchuk.org\/cancerstats."},{"issue":"6","key":"10.1016\/j.clon.2017.01.009_bib2","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S1470-2045(15)70168-3","article-title":"Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials","volume":"16","author":"Chang","year":"2015","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.009_bib3","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.clon.2015.01.006","article-title":"Stereotactic ablative body radiotherapy for lung cancer","volume":"27","author":"Franks","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib4","doi-asserted-by":"crossref","first-page":"E737","DOI":"10.1111\/j.1464-410X.2012.11550.x","article-title":"A\u00a0systematic review of stereotactic radiotherapy ablation for primary renal cell carcinoma","volume":"110","author":"Siva","year":"2012","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.clon.2017.01.009_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2013.03.022","article-title":"Prostate stereotactic ablative body radiotherapy using a standard linear accelerator: toxicity, biochemical and pathological outcomes","volume":"107","author":"Loblaw","year":"2013","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.009_bib6","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.clon.2015.01.011","article-title":"Stereotactic body radiotherapy for prostate cancer","volume":"27","author":"Henderson","year":"2015","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1200\/JCO.2008.19.6329","article-title":"Multi-institutional phase I\/II trial of stereotactic radiation therapy for liver metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib8","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1200\/JCO.2008.19.6386","article-title":"Multi-institutional phase I\/II trial of stereotactic radiation therapy for lung metastases","volume":"27","author":"Rusthoven","year":"2009","journal-title":"J\u00a0Clin Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.009_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.clon.2015.02.003","article-title":"Stereotactic body radiotherapy for oligometastatic disease","volume":"27","author":"Hanna","year":"2015","journal-title":"Clin Oncol"},{"issue":"9","key":"10.1016\/j.clon.2017.01.009_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.clon.2012.04.006","article-title":"The Canadian Association of Radiation Oncology scope of practice guidelines for lung, liver and spine stereotactic body radiotherapy","volume":"24","author":"Sahgal","year":"2012","journal-title":"Clin Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib11","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1748-717X-8-109","article-title":"Brachytherapy emulating robotic radiosurgery in patients with cervical carcinoma","volume":"8","author":"Marnitz","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2147\/OTT.S40370","article-title":"Stereotactic body radiation therapy via helical tomotherapy to replace brachytherapy for brachytherapy-unsuitable cervical cancer patients - a preliminary result","volume":"6","author":"Hsieh","year":"2013","journal-title":"OncoTargets Ther"},{"key":"10.1016\/j.clon.2017.01.009_bib13","doi-asserted-by":"crossref","first-page":"article 25","DOI":"10.3389\/fonc.2012.00025","article-title":"Cyberknife boost for patients with cervical cancer unable to undergo brachytherapy","volume":"2","author":"Haas","year":"2012","journal-title":"Frontiers Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib14","first-page":"898953","article-title":"Stereotactic body radiotherapy as an alternative to brachytherapy in gynecologic cancer","author":"Kubicek","year":"2013","journal-title":"BioMed Res Int"},{"key":"10.1016\/j.clon.2017.01.009_bib15","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ijrobp.2004.09.028","article-title":"Fractionated stereotactic radiotherapy boost for gynecologic tumors: an alternative to brachytherapy?","volume":"52","author":"Molla","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2017.01.009_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1186\/1471-2407-10-637","article-title":"Should helical tomotherapy replace brachytherapy for cervical cancer? Case report","volume":"10","author":"Hsieh","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clon.2017.01.009_bib17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.radonc.2003.10.013","article-title":"Stereotactic boost irradiation for targets in the abdomen and pelvis","volume":"70","author":"Wulf","year":"2004","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2017.01.009_bib18","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijrobp.2012.02.058","article-title":"Use of image-guided stereotactic body radiation therapy in lieu of intracavitary brachytherapy for the treatment of inoperable endometrial neoplasia","volume":"85","author":"Kemmerer","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2017.01.009_bib19","first-page":"5103","article-title":"Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of Korean Radiation Oncology Group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2017.01.009_bib20","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3109\/07357907.2015.1019678","article-title":"Stereotactic body radiotherapy for oligometastases confined to para-aortic region: clinical outcomes and the significance of radiotherapy field and dose","volume":"33","author":"Seo","year":"2015","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clon.2017.01.009_bib21","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijrobp.2008.07.020","article-title":"Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymph node metastases from uterine cervical and corpus cancer","volume":"74","author":"Choi","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2017.01.009_bib22","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1177\/030089161309900509","article-title":"Clinical outcome of stereotactic body radiotherapy for abdominal lymph node metastases","volume":"99","author":"Bonomo","year":"2013","journal-title":"Tumori"},{"key":"10.1016\/j.clon.2017.01.009_bib23","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3892\/or.2014.3412","article-title":"Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results","volume":"32","author":"Macchia","year":"2014","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clon.2017.01.009_bib24","first-page":"415","article-title":"Stereotactic radiotherapy in recurrent gynecological cancer: a case series","volume":"22","author":"Deodato","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/j.clon.2017.01.009_bib25","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1177\/153303461000900509","article-title":"Hypofractionated extracranial stereotactic radiotherapy boost for gynecologic tumors: a promising alternative to high-dose rate brachytherapy","volume":"9","author":"Jorcano","year":"2010","journal-title":"Technol Cancer Res Treat"},{"issue":"22","key":"10.1016\/j.clon.2017.01.009_bib26","doi-asserted-by":"crossref","first-page":"9599","DOI":"10.7314\/APJCP.2014.15.22.9599","article-title":"Evaluation of treatment outcomes of early-stage endometrial cancer radiotherapy: a single center experience","volume":"15","author":"Demiral","year":"2014","journal-title":"Asian Pacif J Cancer Prevent"},{"key":"10.1016\/j.clon.2017.01.009_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.radonc.2009.12.004","article-title":"Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynecological cancer","volume":"94","author":"Guckenberger","year":"2010","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.clon.2017.01.009_bib28","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4999\/uhod.12040","article-title":"Salvage stereotactic body radiosurgery in the management of recurrent gynecological cancer","volume":"23","author":"Yazici","year":"2013","journal-title":"Int J Hematol Oncol"},{"issue":"6","key":"10.1016\/j.clon.2017.01.009_bib29","doi-asserted-by":"crossref","first-page":"591","DOI":"10.7785\/tcrt.2012.500261","article-title":"Re-irradiation: outcome, cumulative dose and toxicity in patients retreated with stereotactic radiotherapy in the abdominal or pelvic region","volume":"11","author":"Abusaris","year":"2012","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.clon.2017.01.009_bib30","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/1748-717X-6-77","article-title":"Robotic image-guided reirradiation of lateral pelvic recurrences: preliminary results","volume":"7","author":"Dewas","year":"2011","journal-title":"Radiat Oncol"},{"issue":"5","key":"10.1016\/j.clon.2017.01.009_bib31","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1177\/153303460900800510","article-title":"Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies","volume":"8","author":"Kunos","year":"2009","journal-title":"Technol Cancer Res Treat"},{"issue":"5","key":"10.1016\/j.clon.2017.01.009_bib32","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/153303460800700504","article-title":"Cyberknife radiosurgery for squamous cell carcinoma of vulva after prior pelvic radiation therapy","volume":"7","author":"Kunos","year":"2008","journal-title":"Technol Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.clon.2017.01.009_bib33","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/IGC.0000000000000028","article-title":"Reirradiation using high-dose-rate interstitial brachytherapy for locally recurrent cervical cancer: a single institutional experience","volume":"24","author":"Mabuchi","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clon.2017.01.009_bib34","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.brachy.2014.01.008","article-title":"Phase II trial of image-based high-dose-rate interstitial brachytherapy for previously irradiated gynecological cancer","volume":"13","author":"Martinez-Monge","year":"2014","journal-title":"Brachytherapy"},{"issue":"1","key":"10.1016\/j.clon.2017.01.009_bib35","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1097\/IGC.0000000000000011","article-title":"Morbidity after pelvic exenteration for gynecological malignancies: a retrospective multicentric study of 230 patients","volume":"24","author":"Chiantera","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.clon.2017.01.009_bib36","first-page":"1008","article-title":"Treatment of endometrial carcinoma with high-dose-rate brachytherapy alone in medically inoperable stage I patients","volume":"77","author":"Kucera","year":"1998","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"4","key":"10.1016\/j.clon.2017.01.009_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/j.ijrobp.2005.04.036","article-title":"Long-term results of high-dose-rate brachytherapy in the primary treatment of medically inoperable stager I-II endometrial carcinoma","volume":"63","author":"Niazi","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655517300353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655517300353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T15:43:18Z","timestamp":1760542998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655517300353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":37,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0936655517300353"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2017.01.009","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Role of Stereotactic Ablative Body Radiotherapy in Gynaecological Cancers: A Systematic Review","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2017.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}